From: Herpesvirus and neurological manifestations in patients with severe coronavirus disease
Viral type | Corticosteroid use | p | Lymphocytopenia | p | Total | ||
---|---|---|---|---|---|---|---|
Yes N (%) | No N (%) | Yes N (%) | No N (%) | ||||
HSV-1 | |||||||
Yes | 8 (88.9) | 1 (11.1) | 0.129a | 6 (66.7) | 3 (33.3) | 0.474a | 9 (100) |
No | 25 (56.8) | 19 (43.2) | 22 (50) | 22 (50) | 44 (100) | ||
HSV-2 | |||||||
Yes | 1 (100) | 0 (0) | 1.000a | 1 (100) | 0 (0) | 1.000a | 1 (100) |
No | 32 (61.5) | 20 (38.5) | 27 (51.9) | 25 (48.1) | 52 (100) | ||
EBV | |||||||
Yes | 11 (73.3) | 4 (26.7) | 0.296b | 10 (66.7) | 5 (33.3) | 0.205b | 15 (100) |
No | 22 (57.9) | 16 (42.1) | 18 (47.4) | 20 (52.6) | 38 (100) | ||
CMV | |||||||
Yes | 12 (52.2) | 11 (47.8) | 0.185b | 11 (47.8) | 12 (52.2) | 0.523b | 23 (100) |
No | 21 (70) | 9 (30) | 17 (56.7) | 13 (43.3) | 30 (100) | ||
VZV | |||||||
Yes | 2 (50) | 2 (50) | 0.627a | 3 (75) | 1 (25) | 0.613a | 4 (100) |
No | 31 (63.3) | 18 (36.7) | 25 (51) | 24 (49) | 49 (100) | ||
HHV-6 | |||||||
Yes | 14 (56) | 11 (44) | 0.374b | 12 (48) | 13 (52) | 0.506b | 25 (100) |
No | 19 (67.9) | 9 (32.1) | 16 (57.1) | 12 (42.9) | 28 (100) | ||
HHV-7 | |||||||
Yes | 14 (66.7) | 7 (33.3) | 0.592b | 8 (381) | 13 (61.9) | 0.082b | 21 (100) |
No | 19 (59.4) | 13 (40.6) | 20 (62.5) | 12 (37.5) | 32 (100) | ||
HHV-8 | |||||||
Yes | 5 (55.6) | 4 (44.4) | 0.715b | 2 (22.2) | 7 (77.8) | 0.087b | 9 (100) |
No | 28 (63.6) | 16 (36.4) | 26 (59.1) | 18 (40.9) | 44 (100) |